Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Batlle

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Ebiomedicine|February 13, 2016
The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?Daniel Batlle, Khaled Boobés, Kiran G Manjee
Experimental Diabetes Research|March 31, 2012
New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathyMaría José Soler, Marta Riera, Daniel Batlle
Kidney International|November 16, 2010
Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKDVaibhav Sahni, Robert M Rosa, Daniel Batlle
Circulation Research|October 2, 2010
Vascular angiotensin-converting enzyme 2: lord of the ring?Daniel Batlle, Jan Wysocki, Mirza S Khan
Diabetes|December 1, 2010
ACE2 and diabetes: ACE of ACEs?Daniel Batlle, Maria Jose Soler, Minghao Ye
Current Opinion in Nephrology and Hypertension|April 15, 2008
New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathyDaniel Batlle, María José Soler, Jan Wysocki
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2013
ACE2 alterations in kidney diseaseMaría José Soler, Jan Wysocki, Daniel Batlle
Medicina Clinica|August 5, 2008
[Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system]María José Soler, Josep Lloveras, Daniel Batlle
Experimental Physiology|January 29, 2008
Angiotensin-converting enzyme 2 and the kidneyMaria Jose Soler, Jan Wysocki, Daniel Batlle
Journal of the American Society of Nephrology : JASN|June 11, 2026
Limitations of Serum Bicarbonate as a Criterion for Metabolic Acidosis in CKD: Implications for Clinical TrialsNabil William Sweis, Bhupinder Singh, Daniel Batlle
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Ebiomedicine|February 13, 2016
The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?Daniel Batlle, Khaled Boobés, Kiran G Manjee
Experimental Diabetes Research|March 31, 2012
New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathyMaría José Soler, Marta Riera, Daniel Batlle
Kidney International|November 16, 2010
Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKDVaibhav Sahni, Robert M Rosa, Daniel Batlle
Circulation Research|October 2, 2010
Vascular angiotensin-converting enzyme 2: lord of the ring?Daniel Batlle, Jan Wysocki, Mirza S Khan
Diabetes|December 1, 2010
ACE2 and diabetes: ACE of ACEs?Daniel Batlle, Maria Jose Soler, Minghao Ye
Current Opinion in Nephrology and Hypertension|April 15, 2008
New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathyDaniel Batlle, María José Soler, Jan Wysocki
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2013
ACE2 alterations in kidney diseaseMaría José Soler, Jan Wysocki, Daniel Batlle
Medicina Clinica|August 5, 2008
[Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system]María José Soler, Josep Lloveras, Daniel Batlle
Experimental Physiology|January 29, 2008
Angiotensin-converting enzyme 2 and the kidneyMaria Jose Soler, Jan Wysocki, Daniel Batlle
Journal of the American Society of Nephrology : JASN|June 11, 2026
Limitations of Serum Bicarbonate as a Criterion for Metabolic Acidosis in CKD: Implications for Clinical TrialsNabil William Sweis, Bhupinder Singh, Daniel Batlle
Pageof 16